glp-1 grocery impact news Food makers warn GLP-1s will have 'lasting influence' on sector As GLP-1 drugs gain popularity

Tirzepatide achieved MASH resolution rates of 44% to 62% across doses in the SYNERGY-NASH trial (up to 73% on the efficacy estimand at 15 mg)

The ISSNs 2023 position stand on EAA supplementation (Ferrando et al., 2023) makes the case directly: EAA requirements increase during caloric deficits , free-form EAAs stimulate MPS more effectively than equivalent intact protein, and doses as low as 1.53 g can trigger a synthesis response at rest

Incretins, however, are rapidly degraded by dipeptidyl peptidase-4 resulting in fleeting half-lives of 12 min (Fig

showing a positive relationship between ferroportin 1 expression (which increases hemoglobin) and ghrelin (which is upregulated during fasting) [8]

The lack of data had previously led societies to rely on expert opinion for guidance

After 4 weeks, increase the dose to 5 mg once weekly